Zhaohong Qin
Ottawa, ON K1H8M5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Tyrosine phosphatase PTP1B impairs presynaptic NMDA receptor-mediated plasticity in a mouse model of Alzheimer's disease.
Journal: Neurobiology of disease
Published: February 15, 2021
Ketamine's schizophrenia-like effects are prevented by targeting PTP1B.
Journal: Neurobiology of disease
Published: January 17, 2021
Neuronal protein-tyrosine phosphatase 1B hinders sensory-motor functional recovery and causes affective disorders in two different focal ischemic stroke models.
Journal: Neural regeneration research
Published: August 14, 2020
Activation of tyrosine phosphatase PTP1B in pyramidal neurons impairs endocannabinoid signaling by tyrosine receptor kinase trkB and causes schizophrenia-like behaviors in mice.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: April 28, 2020
Hyperactivated PTP1B phosphatase in parvalbumin neurons alters anterior cingulate inhibitory circuits and induces autism-like behaviors.
Journal: Nature communications
Published: September 06, 2019
Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: August 30, 2019
Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury.
Journal: Neural regeneration research
Published: March 21, 2018
IRF2BP2-deficient microglia block the anxiolytic effect of enhanced postnatal care.
Journal: Scientific reports
Published: May 12, 2017
Loss of IRF2BP2 in Microglia Increases Inflammation and Functional Deficits after Focal Ischemic Brain Injury.
Journal: Frontiers in cellular neuroscience
Published: May 03, 2017
Functional properties of Claramine: a novel PTP1B inhibitor and insulin-mimetic compound.
Journal: Biochemical and biophysical research communications
Published: December 23, 2014
LMO4 is required to maintain hypothalamic insulin signaling.
Journal: Biochemical and biophysical research communications
Published: May 15, 2014
Last Updated: 09/26/2026